Last edition
News about "RYZUMVI for presbyopia"
US FDA Approves Viatris' RYZUMVI for Presbyopia
Viatris has received US FDA approval for RYZUMVI to treat presbyopia. The eye drop is already approved in the US for pharmacologically induced mydriasis.
RYZUMVI For Presbyopia | 19/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members